NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 21 filers reported holding NEVRO CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $27,411,000 | +7.1% | 24,220,000 | -1.3% | 0.51% | +3.6% |
| Q2 2019 | $25,601,000 | +2.7% | 24,530,000 | -0.4% | 0.50% | -10.0% |
| Q1 2019 | $24,934,000 | +0.1% | 24,620,000 | -8.0% | 0.55% | -8.6% |
| Q4 2018 | $24,907,000 | -9.0% | 26,760,000 | -3.2% | 0.60% | +6.7% |
| Q3 2018 | $27,374,000 | -0.9% | 27,650,000 | +9.0% | 0.56% | -2.9% |
| Q2 2018 | $27,613,000 | -5.4% | 25,359,000 | -0.5% | 0.58% | +1.4% |
| Q1 2018 | $29,179,000 | +21.8% | 25,490,000 | +11.1% | 0.57% | +24.8% |
| Q4 2017 | $23,965,000 | +11.8% | 22,936,000 | +27.2% | 0.46% | +13.1% |
| Q3 2017 | $21,443,000 | +4.7% | 18,028,000 | -5.9% | 0.41% | +3.6% |
| Q2 2017 | $20,471,000 | +7.4% | 19,150,000 | +22.4% | 0.39% | +9.8% |
| Q1 2017 | $19,064,000 | +5.0% | 15,650,000 | -7.9% | 0.36% | +6.9% |
| Q4 2016 | $18,149,000 | +86.4% | 16,992,000 | +126.7% | 0.33% | +136.9% |
| Q3 2016 | $9,736,000 | +2.6% | 7,494,000 | -16.7% | 0.14% | -4.1% |
| Q2 2016 | $9,491,000 | – | 9,000,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,600,000 | $33,560,000 | 1.29% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,840,000 | $33,841,000 | 0.49% |
| Nicholas Investment Partners, LP | 5,530,000 | $6,692,000 | 0.47% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,625,000 | $27,455,000 | 0.43% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 15,650,000 | $19,064,000 | 0.36% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,275,000 | $11,223,000 | 0.29% |
| LINDEN ADVISORS LP | 1,751,000 | $2,130,000 | 0.08% |
| LORD, ABBETT & CO. LLC | 14,387,000 | $17,480,000 | 0.05% |
| AVIVA PLC | 4,500,000 | $5,468,000 | 0.03% |
| Allianz Asset Management GmbH | 24,995,000 | $30,481,000 | 0.03% |